Ryanodine and dihydropyridine binding patterns and ryanodine receptor mRNA levels in myopathic hamster heart

Am J Physiol. 1994 Sep;267(3 Pt 2):H1205-13. doi: 10.1152/ajpheart.1994.267.3.H1205.

Abstract

We have determined the densities of sarcolemmal voltage-dependent Ca2+ channels (VDCC) and Ca(2+)-induced Ca2+ release channels (CICR) of sarcoplasmic reticulum (SR) in the cardiomyopathic hamster heart using [3H]PN-200 and [3H]ryanodine, respectively. Partially purified cardiac membrane preparations from myopathic animals exhibit a twofold higher capacity to bind both [3H]PN-200 and [3H]ryanodine. Crude particulate membrane fractions from normal and cardiomyopathic animals reveal no significant difference in receptor densities for [3H]PN-200, whereas densities for [3H]ryanodine binding sites and mRNA levels are significantly (P < 0.05) diminished in cardiomyopathic animals. Inhibition of [3H]ryanodine binding by either Ca2+ or Mg2+ (in mM) as well as temperature dependence for receptor activation for [3H]ryanodine (Q10) is not significantly different, whereas membranes isolated from cardiomyopathic hearts are 1.4-fold and threefold more sensitive to activation by doxorubicin and Ca2+ (in microM), respectively. Vesicles isolated from myopathic hearts are more sensitive to inhibition of Ca2+ uptake by doxorubicin. The higher densities of binding sites for [3H]PN-200 and [3H]ryanodine observed in partially purified membrane fractions from cardiomyopathic hearts are more likely the result of altered patterns with which T-tubule and CICR channels fractionate in preparations from cardiomyopathic hamster heart rather than transcriptional upregulation and may be a consequence of the deficiency in a dystrophin-associated glycoprotein recently identified. Downregulation and functional changes in CICR channels may alter SR Ca2+ transport and contribute to the progression of cardiomyopathy in the hamster.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Calcium / metabolism
  • Calcium Channels / genetics*
  • Calcium Channels / physiology
  • Cardiomyopathies / metabolism*
  • Cricetinae
  • Dihydropyridines / metabolism*
  • Doxorubicin / pharmacology
  • Electrophysiology
  • Isradipine / metabolism
  • Membrane Proteins / metabolism
  • Muscle Proteins / genetics*
  • Myocardium / metabolism*
  • RNA, Messenger / metabolism*
  • Ryanodine / metabolism*
  • Ryanodine Receptor Calcium Release Channel

Substances

  • Calcium Channels
  • Dihydropyridines
  • Membrane Proteins
  • Muscle Proteins
  • RNA, Messenger
  • Ryanodine Receptor Calcium Release Channel
  • Ryanodine
  • 1,4-dihydropyridine
  • Doxorubicin
  • Calcium
  • Isradipine